ARCHIVES

More Bad News for AVEO As Tivozanib Partner Bids Adieu

This article is from The Cancer Letter archive.

Vol. 39 No. 22 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

NCCN in Transition: New Strategy to Examine Role of Informatics, Revenue Sources and International Programs

June 15, 2012

NCI Moratorium On New OIG Applications; P01 Funding Steadily Drops

May 1, 1992

CTEP Drafts FDA Approval Guidelines

March 4, 1988

Groups’ Growth, Impact Shown by Five-Year Data

March 3, 1978

Did ACS Flip-Flop On Stem Cell Research? Society Says No, Patient Coalition Says Yes

September 10, 1999

NCI CTEP-Approved Trials For the Month of October

October 31, 2014